Phase 1 study of first-in-class dUTPase inhibitor, TAS-114 in combination with S-1 in patients with advanced solid tumors

Autor:	J.-L. Van Laethem, Cristiana Sessa, A.S. Alberto Sobrero, Takekazu Aoyama, Anastasios Stathis, L. Gianni, Antoine Hollebecque, Alessandro Pastorino, K. Saito, Fabio Benedetti, Angelica Fasolo, Kazuhiro Yoshida, Robert Winkler, Jeannette Soria
Rok vydání:	2016
Předmět:	Capecitabine Cancer Research Class (set theory) Oncology business.industry Phase (matter) medicine Cancer research In patient business medicine.drug
Zdroj:	European Journal of Cancer. 69:S117-S118
ISSN:	0959-8049
DOI:	10.1016/s0959-8049(16)32950-1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b4bdbe552971b7a70da00ae73313d889 https://doi.org/10.1016/s0959-8049(16)32950-1 Zobrazit plný text záznamu Full Text from ScienceDirect